Sandbox Financial Partners LLC Acquires Shares of 4,494 Docusign Inc. $DOCU

Key Points

• Sandbox Financial Partners LLC has acquired a new stake in Docusign Inc., purchasing 4,494 shares valued at approximately $350,000 during the 2nd quarter.
• Docusign reported a profit of $0.92 earnings per share for the last quarter, exceeding analysts' expectations and showing an 8.8% increase in year-over-year revenue.
• Institutional investors hold 77.64% of Docusign's stock, with several hedge funds increasing their positions significantly during the first quarter.

Sandbox Financial Partners LLC bought a new stake in Docusign Inc. (NASDAQ:DOCU - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 4,494 shares of the company's stock, valued at approximately $350,000.

Several other hedge funds and other institutional investors also recently modified their holdings of DOCU. Hemington Wealth Management grew its position in Docusign by 318.1% in the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after buying an additional 264 shares during the last quarter. Banque Transatlantique SA purchased a new stake in shares of Docusign in the first quarter valued at about $26,000. Golden State Wealth Management LLC boosted its holdings in shares of Docusign by 519.4% in the first quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after acquiring an additional 322 shares in the last quarter. Summit Securities Group LLC purchased a new stake in shares of Docusign in the first quarter valued at about $34,000. Finally, Wood Tarver Financial Group LLC purchased a new stake in shares of Docusign in the fourth quarter valued at about $37,000. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Docusign

In other Docusign news, CEO Allan C. Thygesen sold 40,000 shares of the stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $77.51, for a total transaction of $3,100,400.00. Following the transaction, the chief executive officer owned 143,983 shares of the company's stock, valued at $11,160,122.33. This trade represents a 21.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Peter Solvik sold 15,000 shares of the stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $81.48, for a total transaction of $1,222,200.00. Following the transaction, the director directly owned 135,253 shares in the company, valued at approximately $11,020,414.44. This represents a 9.98% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 82,533 shares of company stock worth $6,598,028. 1.01% of the stock is currently owned by insiders.

Docusign Trading Down 0.5%

Shares of Docusign stock traded down $0.42 during trading hours on Friday, reaching $84.59. 4,516,106 shares of the company's stock were exchanged, compared to its average volume of 3,404,911. Docusign Inc. has a 52-week low of $57.58 and a 52-week high of $107.86. The firm has a market capitalization of $17.01 billion, a price-to-earnings ratio of 63.60, a price-to-earnings-growth ratio of 4.46 and a beta of 1.02. The company has a fifty day moving average of $76.39 and a 200-day moving average of $79.30.

Docusign (NASDAQ:DOCU - Get Free Report) last released its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The firm had revenue of $800.64 million for the quarter, compared to the consensus estimate of $780.35 million. During the same period in the prior year, the business posted $0.97 earnings per share. The firm's revenue for the quarter was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, equities research analysts anticipate that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.

Docusign declared that its board has approved a stock buyback plan on Thursday, June 5th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 6.6% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board believes its stock is undervalued.

Analyst Upgrades and Downgrades

DOCU has been the topic of a number of analyst reports. Bank of America lifted their price objective on Docusign from $85.00 to $102.00 and gave the company a "neutral" rating in a report on Friday, September 5th. Wells Fargo & Company lifted their price target on Docusign from $80.00 to $85.00 and gave the company an "equal weight" rating in a research note on Friday, September 5th. Royal Bank Of Canada boosted their target price on shares of Docusign from $90.00 to $95.00 and gave the stock a "sector perform" rating in a research report on Friday, September 5th. Argus restated a "hold" rating on shares of Docusign in a research report on Monday, September 8th. Finally, Wedbush decreased their target price on shares of Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a research report on Thursday, June 12th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and fourteen have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $94.14.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.